Platelet-derived serotonin links vascular disease and tissue fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Vascular damage and platelet activation are associated with tissue remodeling in diseases such as systemic sclerosis, but the molecular mechanisms underlying this association have not been identified. In this study, we show that serotonin (5-hydroxytryptamine [5-HT]) stored in platelets strongly induces extracellular matrix synthesis in interstitial fibroblasts via activation of 5-HT2B receptors (5-HT2B) in a transforming growth factor β (TGF-β)–dependent manner. Dermal fibrosis was reduced in 5-HT2B−/− mice using both inducible and genetic models of fibrosis. Pharmacologic inactivation of 5-HT2B also effectively prevented the onset of experimental fibrosis and ameliorated established fibrosis. Moreover, inhibition of platelet activation prevented fibrosis in different models of skin fibrosis. Consistently, mice deficient for TPH1, the rate-limiting enzyme for 5-HT production outside the central nervous system, showed reduced experimental skin fibrosis. These findings suggest that 5-HT/5-HT2B signaling links vascular damage and platelet activation to tissue remodeling and identify 5-HT2B as a novel therapeutic target to treat fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. 5-HT2B is overexpressed in patients with SSc. (A) 5-HT2B was detectable by immunohistochemistry in fibroblasts, keratinocytes, and microvessels of SSc patients and controls. Two representative tissue sections and an isotype control are shown. (B) 5-HT2B expression in SM22-α–negative and α-SMA–positive myofibroblasts. A representative skin section of an SSc patient is shown. SM22-α as specific marker for vascular smooth muscle cells was stained with DAB, the myofibroblast marker α-SMA with Alexa Flour 594 (red), and 5-HT2B with Alexa Flour 488 (green; n = 8 each). The stainings were performed in three independent series. Bars: (A and B [top]) 50 µm; (B, bottom) 10 µm.](https://figures.cochat.ai/paper-figures/2d4bce77e10e467e91ca2a569232e136/platelet-derived-serotonin-links-vascular-disease-and-tissue-fibrosis-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, mice that lack this receptor (5H-T2b-/-) are protected against bleomycin-induced skin fibrosis, just as mice in which the 5H-T2b, receptor is pharmacologically inhibited (149).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
In the citing paper
“This effect runs via the 5H-T2b receptor; inhibition of this receptor with terguride decreases collagen and fibronectin production by fibroblasts.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
In the citing paper
“More recently, it was demonstrated that serotonin directly increases extracellular matrix production in primary skin fibroblasts (149).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840 · cited 1×
“To detect also highly cross-linked collagen, the collagen content in skin samples was analyzed by determination of the hydroxyproline content ( Woessner, 1961 ).”
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,312 · cited 1×
“Nuclear and cytoplasmic extracts were prepared as previously described ( Andrews and Faller, 1991 ; Khelifi et al., 2005 ).”
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
Walther, D. J., Peter, J.-U., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., & Bader, M. (2003) · Science · doi:10.1126/science.1078197 · Cited by 1,570 · cited 4×
“TPH1 # / # mice and 5-HT2B # / # mice have been described previously ( Nebigil et al., 2000 ; Walther et al., 2003b ).”
InfluentialChanges in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472 · cited 1×
“…fibrotic diseases such as systemic sclerosis (SSc) and organ-specific fibrosis such as kidney fibrosis, idiopathic pulmonary fibrosis, and liver cirrhosis share common pathophysiological mechanisms (Bataller and Brenner, 2005; Varga and Abraham, 2007; Strieter and Mehrad, 2009).”
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Increased plasma serotonin in primary pulmonary hypertension
Hervé, P., Launay, J.-M., Scrobohaci, M.-L., Brenot, F., Simonneau, G., Petitpretz, P., Poubeau, P., Cerrina, J., Duroux, P., & Drouet, L. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80156-9 · Cited by 560 · cited 2×
“5-hydroxytryptamine (5-HT; serotonin) is another potent mediator, which is released upon activation of platelets and is elevated in the blood of SSc patients ( Stachów et al., 1979 ; Biondi et al., 1988 ; Hervé et al., 1995 ).”
Life history of the carcinoid tumor of the small intestine
Moertel, C. G., Sauer, W. G., Dockerty, M. B., & Baggenstoss, A. H. (1961) · Cancer · doi:10.1002/1097-0142(196109/10)14:5<901::aid-cncr2820140502>3.0.co;2-q · Cited by 555
A proposed new nomenclature for 5-HT receptors
Humphrey, P. P. A., Hartig, P., & Hoyer, D. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90016-d · Cited by 549 · cited 2×
“The cellular eff ects of 5-HT are mediated by seven families of 5-HT receptors, 5-HT1 to 5-HT7, some of which comprise several diff erent members ( Humphrey et al., 1993 ).”
Drugs and Valvular Heart Disease
Roth, B. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068265 · Cited by 479 · cited 1×
“has been implicated in the development of fibrotic changes by selected ergots such as pergolide or bromocriptine, anorexins like fenfluramine, or drugs of abuse as for example MDMA (3,4-methylenedioxymethamphetamine; also known as ecstasy; Rothman et al., 2000; Setola et al., 2003; Hofmann et al., 2006; Roth, 2007).”
Walther, D. J., Peter, J.-U., Winter, S., Höltje, M., Paulmann, N., Grohmann, M., Vowinckel, J., Alamo-Bethencourt, V., Wilhelm, C. S., Ahnert-Hilger, G., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)01014-6 · Cited by 475 · cited 5×
“TPH1/ mice and 5-HT2B mice have been described previously (Nebigil et al., 2000; Walther et al., 2003b).”
InfluentialImatinib mesylate blocks a non‐Smad TGF‐β pathway and reduces renal fibrogenesis in vivo
Wang, S., Wilkes, M. C., Leof, E. B., & Hirschberg, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-2370com · Cited by 463
Distler, J. H. W., Jüngel, A., Huber, L. C., Schulze‐Horsel, U., Zwerina, J., Gay, R. E., Michel, B. A., Hauser, T., Schett, G., Gay, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22314 · Cited by 383 · cited 5×
“The number of apoptotic and necrotic cells was analyzed as described previously ( Distler et al., 2007a ).”
InfluentialSelf-citationSerotonin 2B receptor is required for heart development
Nebigil, C. G., Choi, D.-S., Dierich, A., Hickel, P., Le Meur, M., Messaddeq, N., Launay, J.-M., & Maroteaux, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9508 · Cited by 381 · cited 2×
“TPH1 # / # mice and 5-HT2B # / # mice have been described previously ( Nebigil et al., 2000 ; Walther et al., 2003b ).”
Self-citationSgonc, R., Gruschwitz, M. S., Dietrich, H., Recheis, H., Gershwin, M. E., & Wick, G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118851 · Cited by 374 · cited 2×
“Patients affected with SSc develop a characteristic microangiopathy as the result of ongoing endothelial cell damage and endothelial cell activation early in the course of the disease, before tissue fibrosis becomes evident (Sgonc et al., 1996; Varga and Abraham, 2007).”
Distler, J. H. W., Jüngel, A., Huber, L. C., Seemayer, C. A., Reich, C. F., Gay, R. E., Michel, B. A., Fontana, A., Gay, S., Pisetsky, D. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409781102 · Cited by 328
Self-citationBonhaus, D. W., Bach, C., DeSouza, A., Salazar, F. H. R., Matsuoka, B. D., Zuppan, P., Chan, H. W., & Eglen, R. M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14977.x · Cited by 305 · cited 3×
“However, the 5-HT2 inhibitors terguride and cyproheptadine as well as the selective 5-HT2B inhibitor SB 204741 ( Goldberg et al., 1979 ; Bonhaus et al., 1995 ; Glusa and Pertz, 2000 ; Jäh-nichen et al., 2005 ) effi ciently prevented bleomycin-induced dermal thickening ( Fig.”
Setola, V., Hufeisen, S. J., Grande-Allen, K. J., Vesely, I., Glennon, R. A., Blough, B., Rothman, R. B., & Roth, B. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1223 · Cited by 304
New Mechanisms of Pulmonary Fibrosis
Strieter, R. M., & Mehrad, B. (2009) · Chest · doi:10.1378/chest.09-0510 · Cited by 284 · cited 1×
“Systemic fi brotic diseases such as systemic sclerosis (SSc) and organ-specifi c fi brosis such as kidney fi brosis, idiopathic pulmonary fi brosis, and liver cirrhosis share common pathophysiological mechanisms ( Bataller and Brenner, 2005 ; Varga and Abraham, 2007 ; Strieter and Mehrad, 2009 ).”
Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton.
Green, M. C., Sweet, H. O., & Bunker, L. E. (1976) · PubMed Central · Cited by 281
Distler, O., del Rosso, A., Giacomelli, R., Cipriani, P., Conforti, M. L., Guiducci, S., Gay, R. E., Michel, B. A., Brühlmann, P., Müller-Ladner, U., et al. (2002) · Arthritis Research & Therapy · doi:10.1186/ar596 · Cited by 281 · cited 1×
“- thrombomodulin and vascular endothelial growth factor, which are increased in the serum of SSc patients ( Soma et al., 1993 ; Mercié et al., 1995 ; Distler et al., 2002 ).”
Self-citationLong-Term Serotonin Administration Induces Heart Valve Disease in Rats
Gustafsson, B. I., Tømmerås, K., Nordrum, I., Loennechen, J. P., Brunsvik, A., Solligård, E., Fossmark, R., Bakke, I., Syversen, U., & Waldum, H. (2005) · Circulation · doi:10.1161/01.cir.0000159356.42064.48 · Cited by 257 · cited 2×
“The lesions are located on the mural and valvular endocardium and consist of a matrix-rich stroma and interspersed myofi broblasts, which were also found in an animal model of carcinoid tumors ( Gustafsson et al., 2005 ).”
Functional activity of serotoninergic and melatoninergic systems expressed in the skin
Slominski, A., Pisarchik, A., Zbytek, B., Tobin, D. J., Kauser, S., & Wortsman, J. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10287 · Cited by 235 · cited 2×
“The profibrotic effects of 5-HT are mediated by 5-HT2B Consistent with a previous study, we observed that three different receptors for 5-HT are expressed in dermal fibroblasts: 5-HT1B, 5-HT2A, and 5-HT2B (Slominski et al., 2003).”
A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver Fibrosis
Ruddell, R. G., Oakley, F., Hussain, Z., Yeung, I., Bryan-Lluka, L. J., Ramm, G. A., & Mann, D. A. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050767 · Cited by 194
Hypoxia‐induced increase in the production of extracellular matrix proteins in systemic sclerosis
Distler, J. H. W., Jüngel, A., Pileckyte, M., Zwerina, J., Michel, B. A., Gay, R. E., Kowal‐Bielecka, O., Matucci‐Cerinic, M., Schett, G., Marti, H. H., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23074 · Cited by 193 · cited 5×
“The number of apoptotic and necrotic cells was analyzed as described previously ( Distler et al., 2007a ).”
InfluentialSelf-citationAkhmetshina, A., Dees, C., Pileckyte, M., Maurer, B., Axmann, R., Jüngel, A., Zwerina, J., Gay, S., Schett, G., Distler, O., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-105627 · Cited by 187 · cited 4×
“Total soluble collagen in cell culture supernatants was quantifi ed using the SirCol collagen assay (Biocolor; Akhmetshina et al., 2008 ).”
InfluentialSelf-citationFli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway
Czuwara-Ladykowska, J., Shirasaki, F., Jackers, P., Watson, D. K., & Trojanowska, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010133200 · Cited by 162
Lawrie, A., Spiekerkoetter, E. F., Martinez, E. C., Ambartsumian, N. S., Sheward, W. J., MacLean, M. R., Harmar, A. J., Schmidt, A.-M., Lukanidin, E. M., & Rabinovitch, M. (2005) · Circulation Research · doi:10.1161/01.res.0000176025.57706.1e · Cited by 156 · cited 1×
“Cells were incubated with the nonselective 5-HT2 inhibitor terguride (0.01–1.0 µM) or the selective inhibitors SB 224289 (5-HT1B), ketanserin (5-HT2A), and SB 204741 (5-HT2B) at concentrations of 0.1 and 1.0 µM ( Kasho et al., 1998 ; Lawrie et al., 2005 ).”
InfluentialQuantitative studies of autotransplantation of human cancer.Preliminary report
Southam, C. M., & Brunschwig, A. (1961) · Cancer · doi:10.1002/1097-0142(196109/10)14:5<1017::aid-cncr2820140516>3.0.co;2-p · Cited by 144
Elevated Levels of Circulating Platelet Aggregates and Beta-Thromboglobulin in Scleroderma
Kahaleh, M. B., OSBORN, I., & LEROY, E. C. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-5-610 · Cited by 131 · cited 4×
“-thrombomodulin, platelet factor 4, and platelet-derived growth factor are elevated in SSc patients ( Kahaleh et al., 1982 ; Postlethwaite and Chiang, 2007 ).”
InfluentialCarcinoid Tumors and Fibrosis: An Association with No Explanation
Modlin, I. M., Shapiro, M. D., & Kidd, M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40507.x · Cited by 130 · cited 3×
“Skin involvement manifests as sclero-derma-like disease with dermal fi brosis ( Zarafonetis et al., 1958 ; Fries et al., 1973 ; Modlin et al., 2004 ).”
Cyproheptadine in Anorexia Nervosa
Goldberg, S. C., Halmi, K. A., Eckert, E. D., Casper, R. C., & Davis, J. M. (1979) · The British Journal of Psychiatry · doi:10.1192/bjp.134.1.67 · Cited by 125
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
Fabre, A., Marchal-Sommé, J., Marchand-Adam, S., Quesnel, C., Borie, R., Dehoux, M., Ruffié, C., Callebert, J., Launay, J., Hénin, D., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00126907 · Cited by 118
Glusa, E., & Pertz, H. H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703341 · Cited by 112
Daxx is required for stress-induced cell death and JNK activation
Khelifi, A. F., d’Alcontres, M. S., & Salomoni, P. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401559 · Cited by 108
Agonism at 5-HT2B receptors is not a class effect of the ergolines
Jähnichen, S., HOROWSKI, R., & Pertz, H. H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.03.010 · Cited by 106
Hofmann, C., Penner, U., Dorow, R., Pertz, H. H., J??hnichen, S., Horowski, R., Latt??, K. P., Palla, D., & Schurad, B. (2006) · Clinical Neuropharmacology · doi:10.1097/00002826-200603000-00005 · Cited by 105
Scleroderma-like Lesions and the Carcinoid Syndrome
Fries, J. F. (1973) · Archives of Internal Medicine · doi:10.1001/archinte.1973.00320100078010 · Cited by 105 · cited 2×
“Skin involvement manifests as sclero-derma-like disease with dermal fi brosis ( Zarafonetis et al., 1958 ; Fries et al., 1973 ; Modlin et al., 2004 ).”
Progression of Metastases and Symptom Improvement from Laparotomy in Midgut Carcinoid Tumors
Makridis, C., Rastad, J., Öberg, K., & Åkerström, G. (1996) · World Journal of Surgery · doi:10.1007/s002689900137 · Cited by 97 · cited 2×
“The accumulation of extra-cellular matrix might be substantial and by far exceed the actual tumor volume ( Moertel et al., 1961 ; Makridis et al., 1996 ).”
Wouters, M. M., Gibbons, S. J., Roeder, J. L., Distad, M. A., Ou, Y., Strege, P. R., Szurszewski, J. H., & Farrugia, G. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.017 · Cited by 95 · cited 2×
“Therefore, fi broblasts from SSc patients and healthy subjects were stimulated with 5-HT at biologically relevant concentrations ( Kasho et al., 1998 ; Wouters et al., 2007 ).”
Jüngel, A., Distler, O., Schulze-Horsel, U., Huber, L. C., Ha, H. R., Simmen, B. R., Kalden, J. R., Pisetsky, D. S., Gay, S., & Distler, J. H. W. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22980 · Cited by 92 · cited 2×
“5 μg siRNA duplexes against 5-HT2B using the human dermal fibroblast Nucleofector kit (Lonza; Jüngel et al., 2007).”
InfluentialSelf-citationPlatelet contributions to the pathogenesis of systemic sclerosis
Postlethwaite, A. E., & Chiang, T. M. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282eeb3a4 · Cited by 84 · cited 2×
“The levels of several platelet-derived molecules such as -thrombomodulin, platelet factor 4, and platelet-derived growth factor are elevated in SSc patients (Kahaleh et al., 1982; Postlethwaite and Chiang, 2007).”
ASSOCIATION OF FUNCTIONING CARCINOID SYNDROME AND SCLERODERMA. I. CASE REPORT
Zarafonetis, C. J. D., Lorber, S. H., & Hanson, S. M. (1958) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195807000-00001 · Cited by 81 · cited 1×
“Skin involvement manifests as sclero-derma-like disease with dermal fi brosis ( Zarafonetis et al., 1958 ; Fries et al., 1973 ; Modlin et al., 2004 ).”
Dermal fibrosis following subcutaneous injections of serotonin creatinine sulphate
MacDonald, R. A., Robbins, S. L., & Mallory, G. K. (1958) · Experimental Biology and Medicine · doi:10.3181/00379727-97-23734 · Cited by 81 · cited 1×
“Others proposed that 5-HT might be the cause of carcinoid-associated fi brosis ( MacDonald et al., 1958 ; Hallen, 1964 ).”
Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon
Biondi, M. L., Marasini, B., Bianchi, E., & Agostoni, A. (1988) · International Journal of Cardiology · doi:10.1016/0167-5273(88)90238-0 · Cited by 78 · cited 8×
“Together with a previous report of an increased serum concentration of 5-HT in SSc (Biondi et al., 1988), these findings suggest that the 5-HT/5-HT2B axis is up-regulated in systemic fibrotic disease.”
InfluentialKatayama, I., & Nishioka, K. (1997) · Journal of Dermatological Science · doi:10.1016/s0923-1811(97)00608-7 · Cited by 69
Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample
Chung, L., Krishnan, E., & Chakravarty, E. F. (2007) · Rheumatology · doi:10.1093/rheumatology/kem273 · Cited by 68 · cited 2×
“The accumulating extracellular matrix disrupts the physiological tissue structure, leading to organ dysfunction and contributing to the high morbidity and increased mortality of aff ected patients ( Chung et al., 2007 ; Steen and Medsger, 2007 ).”
Serotonin enhances the production of type IV collagen by human mesangial cells
Kasho, M., Sakai, M., Sasahara, T., Anami, Y., Matsumura, T., Takemura, T., Matsuda, H., Kobori, S., & Shichiri, M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00114.x · Cited by 64 · cited 3×
“Therefore, fi broblasts from SSc patients and healthy subjects were stimulated with 5-HT at biologically relevant concentrations ( Kasho et al., 1998 ; Wouters et al., 2007 ).”
InfluentialBombesin Inhibits Alveolarization and Promotes Pulmonary Fibrosis in Newborn Mice
Ashour, K., Shan, L., Lee, J., Schlicher, W., Wada, K., Wada, E., & Sunday, M. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1014oc · Cited by 61 · cited 1×
“Others speculated that tachykinins released from carcinoid tumors might mediate tissue fi brosis ( Katayama and Nishioka, 1997 ; Ashour et al., 2006 ).”
Mirtazapine: a review of its clinical efficacy and tolerability
Szegedi, A., & Schwertfeger, N. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.4.631 · Cited by 57 · cited 1×
“…potent inhibitors of 5-HT2 receptors, including cyproheptadine and terguride used in our study as well as mianserin and lisuride, are already in clinical use and are well tolerated ( Obeso et al., 1986 ; von Werner et al., 1989 ; Moertel et al., 1991 ; Szegedi and Schwertfeger, 2005 ).”
Moertel, C. G., Kvols, L. K., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910101)67:1<33::aid-cncr2820670107>3.0.co;2-e · Cited by 54
Clear cell carcinoma of the inguinal region arising from endometriosis
Ahn, G., & Scully, R. E. (1991) · Cancer · doi:10.1002/1097-0142(19910101)67:1<20::aid-cncr2820670105>3.0.co;2-u · Cited by 47
FIBROSIS IN THE CARCINOID SYNDROME
Hallén, A. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92853-3 · Cited by 42 · cited 4×
“All patients and controls signed a valves (Hallen, 1964).”
InfluentialBiogenic amines derived from tryptophan in systemic and cutaneous scleroderma
Stachów, A., Jablonska, S., & Skiendzielewska, A. (1979) · Acta Dermato Venereologica · doi:10.2340/000155555915 · Cited by 35 · cited 4×
“5-hydroxytryptamine (5-HT; serotonin) is another potent mediator, which is released upon activation of platelets and is elevated in the blood of SSc patients ( Stachów et al., 1979 ; Biondi et al., 1988 ; Hervé et al., 1995 ).”
InfluentialDistler, J. H. W., van Hagen, C. C., Hirth, A., Müller‐Ladner, U., Lorenz, H. M., Rosso, A. D., Michel, B. A., Gay, R. E., Nanagara, R., Nishioka, K., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.389 · Cited by 23 · cited 1×
“The mRNA stability assay was performed to investigate whether 5-HT stabilizes collagen or fi bronectin mRNA as described previously ( Distler et al., 2004 ).”
Self-citationPlasma thrombomodulin as a marker of vascular damage in systemic sclerosis.
Mercié, P., Seigneur, M., & Conri, C. (1995) · PubMed · Cited by 17
METHYSERGIDE AND RETROPERITONEAL FIBROSIS
Reimund, E. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90140-1 · Cited by 15
Increase in plasma thrombomodulin in patients with systemic sclerosis.
Soma, Y., Takehara, K., Sato, S., & Ishibashi, Y. (1993) · PubMed · Cited by 15
Pavlovic, M. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.10.1207 · Cited by 15
Saïag, P. (1995) · Archives of Dermatology · doi:10.1001/archderm.1995.01690220115026 · Cited by 13 · cited 2×
“Of note, dermal fi brosis has been reported to regress after eff ective treatment of carcinoid tumors ( Pavlovic et al., 1995 ).”
Lisuride in the treatment of myoclonus.
Obeso, J. A., Rothwell, J. C., Quinn, N. P., Lang, A. E., Artieda, J., & MARSDEN, C. D. (1986) · PubMed · Cited by 10
Research works printed but not linked: 1
- von Werner, 1989, Therapy with terguride, Nichidoku-Iho., 33, 189
Cited by
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843
Self-citationShared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Self-citationUnderstanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Bhattacharyya, S., Wei, J., & Varga, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.149 · Cited by 381
Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
Palumbo-Zerr, K., Zerr, P., Distler, A., Fliehr, J., Mancuso, R., Huang, J., Mielenz, D., Tomcik, M., Fürnrohr, B. G., Scholtysek, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3777 · Cited by 342
Self-citationThe pathogenesis, diagnosis and treatment of Raynaud phenomenon
Herrick, A. L. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.96 · Cited by 302
Metadata
- Authors
- Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., Reiter, R., Alenina, N., Maroteaux, L., Gay, S., Schett, G., Distler, O., & Distler, J. H. W.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University Hospital Zurich (CH)
- ErgoNex Pharma GmbH, CH-9050 Appenzell, Switzerland 3
- Max Delbrück Center (DE)
- Inserm (FR)
- Corresponding author
- Distler, Jörg H.W.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-04-25
- Volume
- 208
- Issue
- 5
- Pages
- 961-972
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3092343
- OpenAlex
- W2025287936
- Cited by
- 266
- References
- 63
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 22 · 2020: 22 · 2019: 14 · 2018: 22 · 2017: 12 · 2016: 20 · 2015: 16 · 2014: 21 · 2013: 21 · 2012: 37
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- serotonin, platelets, 5-HT2B receptor, skin fibrosis, systemic sclerosis, extracellular matrix synthesis, fibroblasts, TGF-beta signaling, platelet activation, vascular injury, tissue remodeling, tryptophan hydroxylase 1, therapeutic target
- MeSH terms
- Animals, Blood Platelets, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Scleroderma, Systemic, Serotonin, Signal Transduction, Platelet Activation, Transforming Growth Factor beta, Mice, Knockout, Receptor, Serotonin, 5-HT2B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.